vs

Side-by-side financial comparison of Avidity Biosciences, Inc. (RNA) and WhiteFiber, Inc. (WYFI). Click either name above to swap in a different company.

WhiteFiber, Inc. is the larger business by last-quarter revenue ($20.2M vs $12.5M, roughly 1.6× Avidity Biosciences, Inc.). WhiteFiber, Inc. runs the higher net margin — -78.1% vs -1398.3%, a 1320.3% gap on every dollar of revenue. WhiteFiber, Inc. produced more free cash flow last quarter ($-32.5M vs $-156.9M).

Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.

Open Fiber S.p.A. is an Italian wholesale only telecommunications company, owned 60% by CDP Equity S.p.A. and 40% by Macquarie Asset Management.

RNA vs WYFI — Head-to-Head

Bigger by revenue
WYFI
WYFI
1.6× larger
WYFI
$20.2M
$12.5M
RNA
Higher net margin
WYFI
WYFI
1320.3% more per $
WYFI
-78.1%
-1398.3%
RNA
More free cash flow
WYFI
WYFI
$124.4M more FCF
WYFI
$-32.5M
$-156.9M
RNA

Income Statement — Q3 FY2025 vs Q3 FY2025

Metric
RNA
RNA
WYFI
WYFI
Revenue
$12.5M
$20.2M
Net Profit
$-174.4M
$-15.8M
Gross Margin
63.1%
Operating Margin
-1513.5%
-71.9%
Net Margin
-1398.3%
-78.1%
Revenue YoY
434.0%
Net Profit YoY
-117.0%
EPS (diluted)
$-1.27
$-0.47

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RNA
RNA
WYFI
WYFI
Q3 25
$12.5M
$20.2M
Q2 25
$3.8M
$18.7M
Q1 25
$1.6M
Q4 24
$3.0M
Q3 24
$2.3M
Q2 24
$2.0M
Q1 24
$3.5M
Q4 23
$2.2M
Net Profit
RNA
RNA
WYFI
WYFI
Q3 25
$-174.4M
$-15.8M
Q2 25
$-157.3M
$-8.8M
Q1 25
$-115.8M
Q4 24
$-102.3M
Q3 24
$-80.4M
Q2 24
$-70.8M
Q1 24
$-68.9M
Q4 23
$-60.4M
Gross Margin
RNA
RNA
WYFI
WYFI
Q3 25
63.1%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
Operating Margin
RNA
RNA
WYFI
WYFI
Q3 25
-1513.5%
-71.9%
Q2 25
-4448.7%
-49.1%
Q1 25
-8360.9%
Q4 24
-4069.6%
Q3 24
-4200.9%
Q2 24
-4040.4%
Q1 24
-2178.6%
Q4 23
-3043.5%
Net Margin
RNA
RNA
WYFI
WYFI
Q3 25
-1398.3%
-78.1%
Q2 25
-4089.3%
-47.3%
Q1 25
-7360.0%
Q4 24
-3439.5%
Q3 24
-3441.7%
Q2 24
-3461.8%
Q1 24
-1943.4%
Q4 23
-2756.2%
EPS (diluted)
RNA
RNA
WYFI
WYFI
Q3 25
$-1.27
$-0.47
Q2 25
$-1.21
Q1 25
$-0.90
Q4 24
$-0.80
Q3 24
$-0.65
Q2 24
$-0.65
Q1 24
$-0.79
Q4 23
$-0.80

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RNA
RNA
WYFI
WYFI
Cash + ST InvestmentsLiquidity on hand
$350.2M
$166.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.9B
$481.1M
Total Assets
$2.1B
$555.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RNA
RNA
WYFI
WYFI
Q3 25
$350.2M
$166.5M
Q2 25
$243.9M
$16.4M
Q1 25
$254.2M
Q4 24
$219.9M
Q3 24
$370.2M
Q2 24
$575.8M
Q1 24
$471.4M
Q4 23
$185.1M
Stockholders' Equity
RNA
RNA
WYFI
WYFI
Q3 25
$1.9B
$481.1M
Q2 25
$1.2B
$308.0M
Q1 25
$1.3B
Q4 24
$1.4B
Q3 24
$1.5B
Q2 24
$1.2B
Q1 24
$830.9M
Q4 23
$500.8M
Total Assets
RNA
RNA
WYFI
WYFI
Q3 25
$2.1B
$555.1M
Q2 25
$1.4B
$386.3M
Q1 25
$1.5B
Q4 24
$1.6B
Q3 24
$1.6B
Q2 24
$1.3B
Q1 24
$951.5M
Q4 23
$628.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RNA
RNA
WYFI
WYFI
Operating Cash FlowLast quarter
$-156.2M
$-16.9M
Free Cash FlowOCF − Capex
$-156.9M
$-32.5M
FCF MarginFCF / Revenue
-1257.6%
-160.8%
Capex IntensityCapex / Revenue
5.7%
77.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-592.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RNA
RNA
WYFI
WYFI
Q3 25
$-156.2M
$-16.9M
Q2 25
$-199.7M
$-6.8M
Q1 25
$-124.8M
Q4 24
$-99.9M
Q3 24
$-65.6M
Q2 24
$-65.0M
Q1 24
$-70.4M
Q4 23
$16.5M
Free Cash Flow
RNA
RNA
WYFI
WYFI
Q3 25
$-156.9M
$-32.5M
Q2 25
$-203.0M
$-137.8M
Q1 25
$-128.6M
Q4 24
$-103.8M
Q3 24
$-67.3M
Q2 24
$-65.5M
Q1 24
$-71.3M
Q4 23
$15.6M
FCF Margin
RNA
RNA
WYFI
WYFI
Q3 25
-1257.6%
-160.8%
Q2 25
-5277.1%
-738.4%
Q1 25
-8174.3%
Q4 24
-3491.0%
Q3 24
-2881.8%
Q2 24
-3204.6%
Q1 24
-2012.3%
Q4 23
713.1%
Capex Intensity
RNA
RNA
WYFI
WYFI
Q3 25
5.7%
77.0%
Q2 25
86.9%
701.7%
Q1 25
238.6%
Q4 24
131.7%
Q3 24
72.9%
Q2 24
26.0%
Q1 24
25.8%
Q4 23
39.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RNA
RNA

Segment breakdown not available.

WYFI
WYFI

Cloud Services$18.0M89%
Colocation Services$1.7M8%
Other$454.6K2%

Related Comparisons